<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00161538</url>
  </required_header>
  <id_info>
    <org_study_id>PASTA V.1.5</org_study_id>
    <nct_id>NCT00161538</nct_id>
  </id_info>
  <brief_title>Pacing of the Atria in Sick Sinus Syndrome Trial Preventive Strategies for Atrial Fibrillation</brief_title>
  <official_title>A Randomized, Prospective Multicenter Study to Examine the Optimal Position of the Atrial Leads for Therapy of the Sinus Node Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic BRC</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vitatron GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Medtronic BRC</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine which of 4 lead positions is most effective for
      pacemaker patients with Sick Sinus Syndrome in order to avoid development of atrial
      fibrillation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The incidence of Atrial Fibrillation (AF) in Sick Sinus Syndrome patients treated with pacing
      is quite high. As AF can cause dizziness, fatigue, thromboembolism and ischemic stroke it is
      clinically relevant. Due to earlier publications pacing modes and lead placement seem to
      influence the incidence of AF. In this study the incidence of AF will be compared between 4
      different atrial lead positions:

        1. Free atrial wall

        2. right atrial appendage

        3. coronary sinus-os

        4. Dual site right atrial pacing: b) plus c).

      The following primary parameters will be evaluated during the study period of 2 years after
      implantation:

        1. Amounts of AF episodes with a duration of &gt; 48 hours

        2. Amounts of AF episodes with a duration of &gt; 30 minutes

        3. Consultations of physicians due to AF Secondarily, AF burden, Incidence of AF in total,
           Quality of Life, implant duration and complications will be evaluated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2000</start_date>
  <completion_date>June 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of AF is determined via memory of the pacemaker, which is saved at every follow-up visit at 1 and 10 days after implant and further on at 3, 6, 12, 18 and 24 months after implant.</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>24-Hour ECG and treadmill exercise as well as echocardiography shall be performed before implant and 6, 12 and 24 months after implant</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treadmill exercise test as well as echocardiography shall be performed before implant and 6, 12 and 24 month after implant.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of Life questionnaires are obtained before implant and 12 and 24 months after implants</measure>
  </secondary_outcome>
  <enrollment>456</enrollment>
  <condition>Sick Sinus Syndrome</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Pacing leads to be implanted according randomization.</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Selection 9000 prevent AF an Diagnose AF</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Sick Sinus Syndrome

          -  Symptomatic sinus bradycardia

          -  Symptomatic SA block

          -  Bradycardia-Tachycardia-Syndrom

          -  Binodal diseases, Sinus Node Syndrome and high degree AV-Block

          -  In case of antiarrhythmic drug therapy: patient must be on a stable dose for at least
             3 months before enrollment

        Exclusion Criteria:

          -  Permanent atrial tachycardia that cannot be transferred into sinus rhythm by drugs or
             electric cardioversion

          -  Decompensated heart failure

          -  Dilatative cardiomyopathy with an ejection fraction &lt; 35%

          -  Hypertrophic obstructive cardiomyopathy

          -  Symptomatic hypo- or hyperthyreosis

          -  Myocardial infarction less than 6 months ago

          -  Planned cardiac surgery intervention

          -  Pregnant woman

          -  Patients under 18 years of age

          -  Patients involved in other studies

          -  Patients, already implanted with other (cardiac) leads

          -  Patients with reduced expectancy of life due to other diseases

          -  Patients who are not able to agree in participation of the study

          -  Patients, who cannot attend follow-up visits due to their place of residence
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan G. Spitzer, MD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Helios-Klinikum Aue</name>
      <address>
        <city>Aue</city>
        <zip>08280</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulantes Herz-Zentrum Dresden</name>
      <address>
        <city>Dresden</city>
        <zip>01099</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Werner-Forssmann-Krankenhaus GmbH</name>
      <address>
        <city>Eberswalde</city>
        <zip>16225</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Joh.-Wolfgang-Goethe-Universität</name>
      <address>
        <city>Frankfurt</city>
        <zip>60596</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Städtisches Krankenhaus Friedrichshafen</name>
      <address>
        <city>Friedrichshafen</city>
        <zip>88048</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitätskrankenhaus Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evang. Krankenhaus</name>
      <address>
        <city>Holzminden</city>
        <zip>37603</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Ingolstadt</name>
      <address>
        <city>Ingolstadt</city>
        <zip>85049</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Kalk GmbH</name>
      <address>
        <city>Köhl</city>
        <zip>51103</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kreiskrankenhaus Leer</name>
      <address>
        <city>Leer</city>
        <zip>26789</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Maria Hilf</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, Pedersen AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet. 1997 Oct 25;350(9086):1210-6.</citation>
    <PMID>9652562</PMID>
  </reference>
  <reference>
    <citation>Rosenqvist M, Brandt J, Schüller H. Long-term pacing in sinus node disease: effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J. 1988 Jul;116(1 Pt 1):16-22.</citation>
    <PMID>3394616</PMID>
  </reference>
  <reference>
    <citation>Prakash A, Saksena S, Hill M, Krol RB, Munsif AN, Giorgberidze I, Mathew P, Mehra R. Acute effects of dual-site right atrial pacing in patients with spontaneous and inducible atrial flutter and fibrillation. J Am Coll Cardiol. 1997 Apr;29(5):1007-14.</citation>
    <PMID>9120152</PMID>
  </reference>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 9, 2005</study_first_submitted>
  <study_first_submitted_qc>September 9, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 12, 2005</study_first_posted>
  <last_update_submitted>October 19, 2006</last_update_submitted>
  <last_update_submitted_qc>October 19, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2006</last_update_posted>
  <keyword>Cardiac Pacing, artificial</keyword>
  <keyword>Atrial fibrillation</keyword>
  <keyword>Pacemaker leads</keyword>
  <keyword>Lead positions</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Sick Sinus Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

